This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
See Cramer's multi-million dollar portfolio for FREE and get his new book Get Rich Carefully! Learn More

Immunomedics Inc.
IMMU : NASDAQ : Health Care

$3.96 | %
Today's Range: 3.86 - 4.08
Avg. Daily Volume: 850,700
04/17/14 - 3:59 PM ET

PEER GROUP: Biotechnology

Ticker Company Name Recent
Net Sales
Net Income
IMMU IMMUNOMEDICS INC 3.99 332.36 n/m 9.80 157.97
CUR NEURALSTEM INC 4.11 354.36 n/m 0.11 -73.04
SNSS SUNESIS PHARMACEUTICALS INC 5.84 350.95 n/m 7.96 111.93
PPHM PEREGRINE PHARMACEUTICLS INC 1.89 350.91 n/m 20.18 3.52
CYTK CYTOKINETICS INC 9.70 350.07 n/m 30.65 305.45
RGLS REGULUS THERAPEUTICS INC 7.81 337.14 n/m 19.57 223.61
GERN GERON CORP 1.94 304.38 n/m 1.28 -52.64
IDRA IDERA PHARMACEUTICALS INC 3.61 297.32 n/m 0.05 12.50
RIGL RIGEL PHARMACEUTICALS INC 3.35 293.23 n/m 7.15 217.77
PGNX PROGENICS PHARMACEUTICAL INC 3.74 260.21 n/m 7.86 -44.04
CCXI CHEMOCENTRYX INC 6.02 259.75 n/m 6.06 11.82
The peer group comparison is based on Major Biotechnology companies of comparable size.

Price Earnings Comparison

IMMU Ind Avg S&P 500
n/m 43.67 18.29

Select the service that is right for you!

Action Alerts PLUS
Try it NOW

Jim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
  • Weekly roundups
TheStreet Quant Ratings
Try it NOW
Only $49.95/yr

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
  • Upgrade/downgrade alerts
Stocks Under $10
Try it NOW

David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
  • Weekly roundups
Dividend Stock Advisor
Try it NOW

Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Alerts when market news affect the portfolio
  • Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Real Money Pro
Try it NOW

All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.

Product Features:
  • Real Money + Doug Kass Plus 15 more Wall Street Pros
  • Intraday commentary & news
  • Ultra-actionable trading ideas
Options Profits
Try it NOW

Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • 100+ monthly options trading ideas
  • Actionable options commentary & news
  • Real-time trading community
  • Options TV

Latest Stock Upgrades/Downgrades

Brokerage Partners

Top Rated Stocks Top Rated Funds Top Rated ETFs